Document is current
Any future updates will be listed below
-
Authors
Girgis, Ragy R.
Slifstein, Mark
D’Souza, Deepak
Lee, Yih
Periclou, Antonia
Ghahramani, Parviz
Laszlovszky, István
Durgam, Suresh
Adham, Nika
Nabulsi, Nabeel
Huang, Yiyun
Carson, Richard E.
Kiss, Béla
Kapás, Margit
Abi-Dargham, Anissa
Rakhit, Ashok
-
Funding
Funding for this research was provided by:
Gedeon Richter, Plc, Budapest, Hungary
Forest Laboratories, LLC, Jersey City, New Jersey, USA, an Allergan affiliate.
- License Information
-
More Information
Article History
Received: 27 October 2015
Accepted: 10 July 2016
First Online: 15 August 2016
Compliance with ethical standards
:
: Support for this research and publication was funded by Forest Laboratories, LLC, Jersey City, New Jersey, USA, an Allergan affiliate, and Gedeon Richter, Plc, Budapest, Hungary. Forest Laboratories and Gedeon Richter were involved in the study design, analysis, interpretation of data, and decision to present these results. Antonia Periclou, Suresh Durgam, and Nika Adham acknowledge a potential conflict of interest as employees of Forest Research Institute, an Allergan affiliate. Yih Lee, Parviz Ghahramani, and Ashok Rakhit acknowledge a potential conflict of interest as employees of Forest Research Institute at the time of the study. István Laszlovszky, Béla Kiss, and Margit Kapás acknowledge a potential conflict of interest as employees of Gedeon Richter Plc. Ragy Girgis has received research funding from Otsuka and Genentech. Mark Slifstein has served as a consultant to Amgen and has received research funding from Otsuka. Anissa Abi-Dargham has served as a consultant for Roche, Otsuka, Forum, and Amgen and has received research support from Takeda, Forest Laboratories, Pierre Fabre, and CHDI Foundation. Nabeel Nabulsi had received royalty payments from the University of Texas M.D. Anderson Cancer Center from patented work. Deepak D’Souza, Richard Carson, and Yiyun Huang have no disclosures to report pertaining to this work.
